Natco Pharma shares decline nearly 5 percent after Q3 results
"The decline in profits during the quarter compared to last year was predominantly due to margin reduction of Oseltamivir in the USA market," Natco Pharma said.
New Delhi: Shares of Natco Pharma fell nearly 5 per cent Wednesday after the company reported a 26.72 per cent fall in consolidated net profit for the December 2018 quarter.
The company's stock dropped 4.68 per cent to close at Rs 635 on BSE. During the day, it plunged 6.88 per cent to Rs 620.30 -- its 52-week low.
Read Also: Natco Pharma submits new drug application with USFDA for generic Ibrutinib tablets
Drug firm Natco Pharma Tuesday reported a 26.72 per cent fall in consolidated net profit to Rs 159.3 crore for the December 2018 quarter, mainly on account of margin reduction of Oseltamivir in the US market.
Read Also: Natco Pharma ventures into agrichemical space, sets up Rs 100 crore facility in AP
It had posted a net profit of Rs 217.4 crore for the corresponding quarter of the previous fiscal, Natco Pharma said in a filing to BSE.
Consolidated total revenue of the company stood at Rs 580 crore for the quarter under consideration as against Rs 573.6 crore for the same period a year ago.
"The decline in profits during the quarter compared to last year was predominantly due to margin reduction of Oseltamivir in the USA market," Natco Pharma said.
Read Also: Natco Pharma Q2 Profit up 35 percent to Rs 583 Crore
Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd